NextCell Pharma AB
556965-8361ActiveDeveloping pioneering cell therapies for autoimmune diseases and diabetes.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 2014
- Founded
Key Decision Makers
Mathias Svahn
Chief Executive Officer
Eric Gustafsson
CFO
Lindsay Davies
CSO / CEO of QVance
Sofia Sisay
Head of Clinical Trials
+5 more contacts in Funnelfeedr
Description
NextCell Pharma AB is a Swedish biopharmaceutical company focused on revolutionizing treatment for severe and incurable diseases using cell therapies. The company operates three core business areas: ProTrans, Cellaviva, and QVance, all centered around advanced therapy medicinal products (ATMPs). The...
Tags
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556965836101
Decision Makers
9 contacts in FunnelfeedrMathias Svahn
Chief Executive Officer
Eric Gustafsson
CFO
Lindsay Davies
CSO / CEO of QVance
Sofia Sisay
Head of Clinical Trials
Hans-Peter Ekre
Chairman of the Board
Eva Sjökvist Saers
Board Member
Camilla Myhre Sandberg
Board member
Sofie Falk Jansson
CEO of Cellaviva
Edvard Smith
Medical Director
Similar Companies
20 similar companies in FunnelfeedrCellaviva AB
5–9 employeesScandinavia's largest private bank storing family stem cells for future health.
QVance AB
1–4 employeesSpecialist quality control analytics provider for cell and gene therapies.
Xintela AB
10–19 employeesDeveloping stem cell and targeted cancer therapies for unmet needs.
Xbrane Biopharma AB
20–49 employeesDeveloping cost-effective biosimilars using proprietary platform technology.
Swedish StromaBio AB
2 employeesClinical stage biopharma developing MSC therapies for ARDS and Alzheimer's.
Browse More
NextCell Pharma AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo